Indeed, in breast cancer, Orai3 is overexpressed and its expression is under the control of estrogen receptor alpha (ERα) that regulates Ca2+ entry, cell proliferation and survival of estrogen receptor-positive MCF-7 cell line [16, 17]. The gene discussed is ORAI3; the disease is breast cancer.